Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Cytokinetics (NASDAQ:CYTK)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Cytokinetics Charts.

Cytokinetics (NASDAQ:CYTK)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Cytokinetics Charts.

Cytokinetics Inc News

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Friday 3 January 2025 (2 days ago) • GlobeNewswire Inc.

Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
Monday 23 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
Thursday 19 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 16 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 16 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 16 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 12 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 10 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 10 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 December 2024 (1 month ago) • Edgar (US Regulatory)

More Cytokinetics Inc News Articles

Lehman Brothers Financial (CE)

Kraig Biocraft Laborator... (QB)

Anavex Life Sciences

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Elite Pharmaceuticals (QB)

Decentral Life (PK)

Lightwave Logic

Digital Brand Media and ... (PK)

Bioelectronics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions